Cancer immunotherapy is a type of cancer treatment that uses the body's own immune system to fight cancer cells. The immune system is a complex network of cells and organs that work together to protect the body from infection and disease. Cancer cells are abnormal cells that grow out of control and can invade other tissues in the body.
The immune system works to destroy these cancer cells, but sometimes it is not strong enough to do so on its own. Cancer immunotherapy can help the immune system work better against cancer cells. Cancer cells often have proteins on their surface that can trick the immune system into thinking they are normal cells.
Monoclonal antibodies are man-made proteins that mimic the body's natural antibodies. Antibodies are substances produced by the immune system that help to destroy infectious organisms and toxins. Monoclonal antibodies can be made to target specific cancer cells. When these antibodies attach to cancer cells, they can help the immune system to destroy them.
Cytokines are proteins that are produced by the body in response to infection or inflammation. They help to regulate the immune system and can promote or inhibit the growth of cancer cells. Checkpoint inhibitor therapy uses drugs that block certain proteins that normally keep the immune system from attacking cancer cells. This allows the immune system to attack and destroy the cancer cells.
Adoptive cell transfer therapy is a type of immunotherapy that uses laboratory-grown immune cells to fight cancer. Immune cells are collected from the patient's blood or tumor and then grown in the laboratory. These immune cells are then injected back into the patient, where they help to fight the cancer cells.
Vaccines are substances that are used to stimulate the immune system to produce antibodies against a specific disease.
Clinical trials are underway to test the safety and effectiveness of these treatments. If you are interested in learning more about it, talk to your doctor or contact a local cancer center.
The concept of 'teaching' the immune system to recognize and destroy cancer cells is in a new era. Anticancer immunotherapy is just beginning with the long-term control of cancer cells. This is called Immune therapy, which uses the body's own immune system to target and kill these disease-carrying cells.
This video provides a simple, clear, and vivid explanation of what cancer immunotherapy is, how this emerging treatment works, and how it will contribute to the fight against the disease.
A newly patented discovery called the CC Formula is a form of Cancer Immunotherapy, the developers of the CC Formula have designed a way to help the immune system recognize cancer cells and strengthen its response so that it will then destroy the cancer cells. The CC Formula, when used in combination with other treatments, it has the potential to improve the quality of life for cancer patients and increase their chances of survival.
The developer of the CC formula is committed to immunotherapy development, specifically moving non-invasive, targeted anti-cancer therapies through development and into markets where significant unmet medical needs to exist such as disenfranchised cancer and other serious diseases.
The developer is supporting extremely promising research focused on developing and commercializing innovative immunotherapy technology in the United States and in international markets. We are currently conducting research on the CC Treatment, a proprietary patent-application formulation. The purpose of the research is to determine the effectiveness of the formula in identifying and/or treating certain types of non-performing cells in humans and other animals.